Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236394-03-000006
Filing Date
2003-07-24
Accepted
2003-07-24 13:06:43
Documents
1
Period of Report
2003-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 10058
  Complete submission text file 0001236394-03-000006.txt   11962
Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMYLIN PHARMACEUTICALS INC 9373 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address AMYLIN PHARMACEUTICALS INC 9373 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 8585522200
KOLTERMAN ORVILLE G (Reporting) CIK: 0001236394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 03800426